TOPLINE: In individuals with seropositive arthralgia, the risk of developing rheumatoid arthritis (RA) rose in the presence of high titers of anti–citrullinated peptide antibodies (ACPAs) and […]

TOPLINE: Deucravacitinib (Sotyktu) demonstrated efficacy in treating patients with active psoriatic arthritis (PsA), achieving higher American College of Rheumatology (ACR) 20 response rates (ie, ≥ 20% […]

TOPLINE: A randomized controlled trial showed that a 6-week telephone-delivered Walk With Ease (WWE-T) Program improved physical function, arthritis management self-efficacy, and impairment related to daily […]

TOPLINE: In patients with psoriatic arthritis (PsA), metabolic syndrome (MetS) was associated with degenerative and metabolic changes in the spine and entheses but not with more […]

TOPLINE: Ultrasonography (US)-identified features like osteophytes, effusion, meniscal extrusion, cartilage damage, calcium crystals, and popliteal cysts were associated with knee symptoms, radiographic knee osteoarthritis (KOA), and […]

TOPLINE: Ixekizumab reduced erosion and increased backfill in the sacroiliac joints of biologic disease-modifying antirheumatic drug (bDMARD)–naive patients with radiographic axial spondyloarthritis (r-axSpA) by week 16, […]

TOPLINE: Male patients with axial spondyloarthritis who received advanced therapies showed higher response rates than female patients, with similar differences observed across different medication classes. METHODOLOGY: […]

TOPLINE: Prolonged remission was observed in 72% of patients with systemic lupus erythematosus (SLE) who were treated with a consistent 200 mg daily dose of hydroxychloroquine. […]